期刊文献+

儿童肿瘤临床分子诊断研究进展 被引量:1

下载PDF
导出
摘要 分子诊断是指对编码与疾病相关的各种结构蛋白、酶、抗原抗体、免疫活性分子基因的检测。目前儿童肿瘤的临床分子诊断主要依赖于肿瘤标志物检测。肿瘤标志物是恶性肿瘤在发生、发展过程中,由癌基因或抑癌基因和其它肿瘤相关基因及其产物异常表达所产生的一些抗原和生物活性物质。已经知道肿瘤是一种异质性疾病,其发生与细胞分化、凋亡、转移及血管生成等多种信号传导途径紊乱有关。
出处 《临床小儿外科杂志》 CAS 2014年第3期233-235,237,共4页 Journal of Clinical Pediatric Surgery
  • 相关文献

参考文献22

  • 1Cessna MH, Zhou H, Perkins SL, et al. Are myogenin and MyoD1 expression specific for rhabdomyosarcoma?. A study of 150 cases,with emphasis on spindle cell mimics[ J]. The American journal of surgical pathology, 2001,25 (9) : 1150- 1157.
  • 2Lujambio A, Calin GA, Villanueva A, et al. A microRNA DNA methylation signature for human cancer metastasis [ J ]. Proceedings of the National Academy of Sciences,2008,105 (36): 13556-13561.
  • 3Miyachi M, Tsuchiya K, Yoshida H, et al. Circulating muscle- specific microRNA,miR-206 ,as a potential diagnostic mark- er for rhabdomyosarcoma [ J ]. Biochemical and biophysical research communications, 2010, 400( 1 ) : 89-93.
  • 4Hu SI, Carozza M, Klein M, et al. Human HtrA, an evolu- tionarily conserved sefine protease identified as a differenti- ally expressed gene product in osteoarthritic cartilage [ J ]. Journal of Biological Chemistry, 1998,273 ( 51 ) : 34406 - 34412.
  • 5Clausen T, Kaiser M, Huber R, et al. HTRA proteases : regu- lated proteolysis in protein quality control [ J ]. Nature Re- views Molecular Cell Biology,2011,12(3) : 152-162.
  • 6D' Angelo V,Pecoraro G,Indolfi P,et al. Expression and lo- calization of serine protease Htral in neuroblastoma: correla- tion with cellular differentiation grade [ J ]. Journal of neuro- oncology,2014 : 1-8.
  • 7Fine SW,Lisanti MP,Argani P,et al. Caveolin-3 is a sensi- tive and specific marker for rhabdomyosarcoma [ J ]. Applied Immunohistochemistry & Molecular Morphology, 2005, 13 (3) : 231-236.
  • 8Gratias EJ ,Jennings LJ, Anderson JR, et al. Gain of 1 q is as- sociated with inferior event - free and overall survival in pa- tients with favorable histology Wilms tumor: A report from the Childre Oncology Group [ J ]. Cancer,2013,119 ( 21 ) : 3887-3894.
  • 9Segers H, Heuvel-Eibfink MM, Williams RD, et al. Gain of lq is a marker of poor prognosis in Wilms" tumors [J]. Genes, Chromosomes and Cancer, 2015,52 ( 11 ) : 1065 - 1074.
  • 10Missiaglia E, Williamson D, Chisholm J, et al. PAX3/ FOXO1 fusion gene status is the key prognostie molecular marker in rhabdomyosarcoma and significantly improves current risk stratification [ J ]. Journal of Clinical Oneology, 2012,30(14) : 1670-1677.

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部